Britain’s medical regulatory agency has approved the resumption of a trial testing whether hydroxychloroquine, the malaria drug favored by U.S. President Donald Trump, might help prevent health workers from contracting…

Read more »

The post U.K. OKs Resumption of Hydroxychloroquine Trial appeared first on Hamodia.

In related news:

  1. WHO Set to Resume Hydroxychloroquine Trial in Battle Against COVID-19
  2. France Bans Hydroxychloroquine to Treat COVID-19
  3. WHO to Temporarily Stop Study of Hydroxychloroquine
  4. Schumer Calls on VA to Explain Use of Hydroxychloroquine on Veterans
  5. Novartis, FDA Agree to Malaria Drug Trial Against COVID-19